1762 — Chunghwa Chemical Synthesis & Biotech Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapMomentum Trap

Market Cap
TWD2.76bn
Enterprise Value
TWD3.35bn
Revenue
TWD804.88m

Annual balance sheet for Chunghwa Chemical Synthesis & Biotech Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	195	301	270	222	216
Net Total Accounts Receivable
Net Total Receivables	396	312	257	208	118
Total Inventory
Prepaid Expenses
Total Current Assets	1,357	1,449	1,788	1,441	1,059
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,868	1,964	2,292	2,199	2,061
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	4,381	4,564	5,172	4,763	4,317
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	635	614	831	425	357
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	1,487	1,371	1,821	1,406	1,230
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	2,894	3,193	3,350	3,357	3,087
Total Liabilities & Shareholders' Equity	4,381	4,564	5,172	4,763	4,317
Total Common Shares Outstanding